<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03333408</url>
  </required_header>
  <id_info>
    <org_study_id>LSUHSC-IRB 9908</org_study_id>
    <nct_id>NCT03333408</nct_id>
  </id_info>
  <brief_title>Determining the Necessity for Postoperative Antibiotics After Salivary Stent Placement</brief_title>
  <official_title>Determining the Necessity for Postoperative Antibiotics After Salivary Stent Placement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Our Lady of the Lake Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Louisiana State University Health Sciences Center in New Orleans</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Our Lady of the Lake Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Salivary duct stent placement is a common practice to maintain duct patency after salivary
      duct repair or interventional sialendoscopy; procedures performed to manage salivary duct
      pathology such as stenosis, traumatic injury or most commonly salivary duct stones. It is
      common practice for patients to receive perioperative antibiotics while undergoing
      interventional sialendoscopy and postoperative oral antibiotic therapy with Clindamycin or
      Augmentin for 10-14 days, if a short term (2 week) salivary duct stenting was considered
      necessary due to the nature of the intervention. However, In reviewing the literature, there
      are controversial trials that indicate post-operative antibiotics may not be best practice in
      all surgical scenarios, as the adverse events ie. gastrointestinal disturbances, nausea,
      Clostridium difficile (C.diff) infection and antibiotic resistance over time surrounding
      overuse of antibiotics may outweigh the clinical need for the antibiotic regiment and the
      chances of post-operative infection.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2017</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative infection</measure>
    <time_frame>2 weeks</time_frame>
    <description>The primary endpoint will be the determination of clinical infection between the time points post-operation to the 2 week follow-up visit when the stent is removed as indicated by evidence of purulence or erythema at the surgical site, fever and elevated white blood cell count.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Salivary Duct</condition>
  <arm_group>
    <arm_group_label>Group A (Antibiotic)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group A will receive postoperative oral antibiotics for 10 - 14 days (Clindamycin or Augmentin) upon discharge.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B (no Antibiotic)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Group B will not be given postoperative oral antibiotics upon discharge.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Postoperative Oral Antibiotics (Clindamycin or Augmentin)</intervention_name>
    <description>Patients will receive postoperative oral antibiotics (Clindamycin or Augmentin) for 10-14 days upon discharge.</description>
    <arm_group_label>Group A (Antibiotic)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All adult patients (18 years of age or older) who are undergoing salivary duct surgery
             and stent placement at Our Lady of the Lake Regional Medical Center

        Exclusion Criteria:

          -  Patients who are unwilling to consent to the study and/or to being placed in a
             randomized arm of either receiving post-operative antibiotics or not receiving
             post-operative antibiotics

          -  Patients with acute infections at the time of surgery

          -  Patients who are immunocompromised

          -  Patients who are recruited but then have early dislodgement of the stent

          -  Patients who do not complete their postoperative antibiotic therapy due to intolerance
             or antibiotic side effects. However, data on these patients will be recorded to
             provide an observational results that will support the need for this investigation on
             antibiotic use.

          -  Patients who are in the non-post operative antibiotic arm but choose to put themselves
             on antibiotics without consultation from the physician
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rohan Walvekar, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Our Lady of the Lake Regional Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rohan Walvekar, M.D.</last_name>
    <phone>225-765-1765</phone>
    <email>rwalve@lsuhsc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Leslie Son, Ph.D.</last_name>
    <phone>225-757-4165</phone>
    <email>lson@lsuhsc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Our Lady of the Lake Regional Medical Center</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70808</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christine LeBoeuf, DNP</last_name>
      <phone>225-765-5956</phone>
      <email>christine.leboeuf@fmolhs.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Lang MS, Gonzalez ML, Dodson TB. Do Antibiotics Decrease the Risk of Inflammatory Complications After Third Molar Removal in Community Practices? J Oral Maxillofac Surg. 2017 Feb;75(2):249-255. doi: 10.1016/j.joms.2016.09.044. Epub 2016 Oct 6.</citation>
    <PMID>28341449</PMID>
  </reference>
  <reference>
    <citation>Taub D, Yampolsky A, Diecidue R, Gold L. Controversies in the Management of Oral and Maxillofacial Infections. Oral Maxillofac Surg Clin North Am. 2017 Nov;29(4):465-473. doi: 10.1016/j.coms.2017.06.004. Epub 2017 Aug 18. Review.</citation>
    <PMID>28823889</PMID>
  </reference>
  <reference>
    <citation>Fleming-Dutra KE, Hersh AL, Shapiro DJ, Bartoces M, Enns EA, File TM Jr, Finkelstein JA, Gerber JS, Hyun DY, Linder JA, Lynfield R, Margolis DJ, May LS, Merenstein D, Metlay JP, Newland JG, Piccirillo JF, Roberts RM, Sanchez GV, Suda KJ, Thomas A, Woo TM, Zetts RM, Hicks LA. Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011. JAMA. 2016 May 3;315(17):1864-73. doi: 10.1001/jama.2016.4151.</citation>
    <PMID>27139059</PMID>
  </reference>
  <reference>
    <citation>Dhiwakar M, Clement WA, Supriya M, McKerrow W. Antibiotics to reduce post-tonsillectomy morbidity. Cochrane Database Syst Rev. 2012 Dec 12;12:CD005607. doi: 10.1002/14651858.CD005607.pub4. Review.</citation>
    <PMID>23235625</PMID>
  </reference>
  <reference>
    <citation>Aljfout Q, Alississ A, Rashdan H, Maita A, Saraireh M. Antibiotics for Post-Tonsillectomy Morbidity: Comparative Analysis of a Single Institutional Experience. J Clin Med Res. 2016 May;8(5):385-8. doi: 10.14740/jocmr2523w. Epub 2016 Mar 20.</citation>
    <PMID>27081424</PMID>
  </reference>
  <reference>
    <citation>Santana RS, Viana Ade C, Santiago Jda S, Menezes MS, Lobo IM, Marcellini PS. The cost of excessive postoperative use of antimicrobials: the context of a public hospital. Rev Col Bras Cir. 2014 May-Jun;41(3):149-54. English, Portuguese.</citation>
    <PMID>25140644</PMID>
  </reference>
  <reference>
    <citation>Chen S, Le CH, Liang J. Practice patterns in endoscopic dacryocystorhinostomy: survey of the American Rhinologic Society. Int Forum Allergy Rhinol. 2016 Sep;6(9):990-7. doi: 10.1002/alr.21759. Epub 2016 Apr 6.</citation>
    <PMID>27060784</PMID>
  </reference>
  <reference>
    <citation>Araujo da Silva AR, Albernaz de Almeida Dias DC, Marques AF, Biscaia di Biase C, Murni IK, Dramowski A, Sharland M, Huebner J, Zingg W. Role of antimicrobial stewardship programmes in children: a systematic review. J Hosp Infect. 2018 Jun;99(2):117-123. doi: 10.1016/j.jhin.2017.08.003. Epub 2017 Aug 12. Review.</citation>
    <PMID>28807835</PMID>
  </reference>
  <reference>
    <citation>Stultz JS, Doern CD, Godbout E. Antibiotic Resistance in Pediatric Urinary Tract Infections. Curr Infect Dis Rep. 2016 Dec;18(12):40. Review.</citation>
    <PMID>27761778</PMID>
  </reference>
  <reference>
    <citation>Phuong NTK, Hoang TT, Van PH, Tu L, Graham SM, Marais BJ. Encouraging rational antibiotic use in childhood pneumonia: a focus on Vietnam and the Western Pacific Region. Pneumonia (Nathan). 2017 Apr 25;9:7. doi: 10.1186/s41479-017-0031-4. eCollection 2017. Review.</citation>
    <PMID>28702309</PMID>
  </reference>
  <reference>
    <citation>Linder JA. Editorial commentary: antibiotics for treatment of acute respiratory tract infections: decreasing benefit, increasing risk, and the irrelevance of antimicrobial resistance. Clin Infect Dis. 2008 Sep 15;47(6):744-6. doi: 10.1086/591149.</citation>
    <PMID>18694343</PMID>
  </reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 20, 2017</study_first_submitted>
  <study_first_submitted_qc>November 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2017</study_first_posted>
  <last_update_submitted>November 2, 2017</last_update_submitted>
  <last_update_submitted_qc>November 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Clindamycin</mesh_term>
    <mesh_term>Clindamycin palmitate</mesh_term>
    <mesh_term>Clindamycin phosphate</mesh_term>
    <mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

